“As I lay dying” – A Powerful Personal Exhortation


Laurie Becklund

This moving opinion piece in the LA Times was just shared with me by Adam Carroll (our CSO and co-founder), which was written by a distinguished foreign correspondent, Laurie Becklund, who just died of breast cancer.

In this piece Laurie lays a withering blow on modern healthcare and advancements in personalized/precision medicine through a couple of highly informed paragraphs:

“We now know that breast cancer is not one disease. What works for one person might not for another: There is no one “cure.” We are each, in effect, one-person clinical trials. Yet the knowledge generated from those trials will die with us because there is no comprehensive database of metastatic breast cancer patients, their characteristics and what treatments did and didn’t help them.”

“In the Big Data-era, this void is criminal. Consider what Wall Street does. Even the tiniest companies can see how much stock they sell, compare themselves to cohorts, review history, predict trends. Why can’t we create such a database for cancer patients, so we can all learn from patient experiences and make more educated decisions on what treatments will extend and improve lives?”

Who is going to create such a database, which can collect the individual information available from the countless “one-person trials” described by Laurie?


Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access